Home >  Blog >  Decoding CVAD Terminology in Oncology

Decoding CVAD Terminology in Oncology

Posted on 7 August 2024

Clear communication is vital in healthcare, yet the lack of standardized terminology can create obstacles. A recent scoping review focused on central venous access devices (CVADs) in cancer patients, uncovering terminologies, complications, and reasons for premature removal. Here's a concise look at their findings:

Diverse Terminologies

The study, led by Kerrie Curtis and team, explored databases from 2017 to 2022, analyzing 292 studies. They found a staggering 213 unique terms for CVADs, highlighting the need for standardized language to ensure seamless healthcare transitions.

Complications and Removal

Surprisingly, definitions for complications and removal reasons were lacking in many studies—only 57% detailed complications, and 44% outlined removal reasons. This gap hampers patient care and research reliability.

Call to Action

The review emphasizes the urgency of standardizing CVAD terminologies. Clarity isn't just about semantics; it's about enhancing patient safety, refining research, and improving oncology care.

In Conclusion

Standardized language is key in oncology. By aligning CVAD definitions, we bridge communication gaps, fortify patient care, and drive research forward for better outcomes in the fight against cancer.

Read More: https://shmpublications.onlinelibrary.wiley.com/doi/10.1002/jhm.13376 

Authors: Kerrie Curtis, Karla Gough, Meinir Krishnasamy, Elena Tarasenko, Geoff Hill & Samantha Keogh 

Address

Griffith University
Nathan
Queensland
Australia 4111